Stryker stock: Barclays maintains USD 375.00 target for Stryker stock

Published on 10/19/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 6.59 billion in the second quarter. Stryker stock costs EUR 260.85 on October 19, 2026, down 0.25 percent versus the Xetra close.

Analyst target and reporting date

On October 13, 2026, Barclays maintained a USD 375.00 target for Stryker.
Second-quarter revenue reached USD 6.59 billion, up 9.40 percent year over year.
Stryker stock traded at EUR 260.85 at 2:58 p.m. CEST at Lang & Schwarz on October 19, 2026, 0.25 percent below the Xetra close of October 16, 2026.
Stryker is scheduled to report earnings on October 29, 2026, after the close.

Aquarellbild eines modernen Bürocampus mit Glasfassaden und Grünanlage am Teich — Aquarellmalerei eines modernen Firmencampus symbolisiert den Hauptsitz von Stryker Corp. US8636671013 in ruhiger Parklandschaft, Illustration mit AI erstellt.

Barclays maintained its Buy rating and a USD 375.00 price target for Stryker on October 13, 2026, according to Gekko. Against the USD 294.66 NYSE price dated October 16, 2026, the target stands 27.27 percent above the price. Stryker traded at EUR 260.85 at Lang & Schwarz on October 19, 2026 at 2:58 p.m. CEST, down 0.25 percent versus the Xetra close of October 16, 2026.

Second-quarter revenue reached USD 6.59 billion

Stryker reported second-quarter 2026 revenue of USD 6.59 billion, an increase of 9.40 percent from the year-earlier quarter. MarketBeat reported that quarterly earnings per share reached USD 3.69, compared with a consensus estimate of USD 3.49. The figures place operating performance alongside the more cautious analyst revisions visible in October.

Price stays below the yearly high

The Lang & Schwarz price is EUR 76.45 below the Xetra close of October 16, 2026. In the primary-market quote dated October 16, 2026, Stryker stood at USD 294.66, within a 52-week range of USD 267.00 to USD 392.55. The price was 25.00 percent below that high and 10.35 percent above the low. Trading volume was 3,377,110 shares against an average of 2,602,573 shares in the same quote.

Valuation and the October 29 date

Stryker had a market capitalization of USD 113.0 billion and a price-to-earnings ratio of 30.53 in the October 16, 2026 market record. Gekko lists October 29, 2026 as the next earnings date, with the report expected after the US market close. The calendar date gives the next clear test for the revenue trend and the analyst view.

Comparison with peers

Stryker Corp.: minus 0.25 percent, P/E 30.53, market capitalization USD 113.0 billion.
Medtronic (NYSE, USD): minus 0.73 percent, P/E 23.34, market capitalization USD 121.2 billion.
Abbott Laboratories (NYSE, USD): plus 0.19 percent, P/E 33.72, market capitalization USD 181.5 billion.

Euro price and investor reference

Stryker's euro quotation was 0.25 percent below the Xetra close of October 16, 2026, while the primary-market valuation remained above its 52-week low and below its 52-week high. The further course of trading is shown by the continuously updated real-time quote of Stryker stock.